BMC Genomics is a premier open-access journal dedicated to advancing the field of genomics through the dissemination of high-quality research articles. Published by BMC, a renowned leader in open-access publishing, this journal has built a solid reputation since its inception in 2000, making significant contributions to the areas of biotechnology and genetics. Holding a prestigious Q1 ranking in Biotechnology and Q2 in Genetics as of 2023, it serves as an essential platform for researchers, professionals, and students alike, facilitating the exchange of innovative ideas and data. With an impactful presence in the Scopus rankings, BMC Genomics currently stands at Rank #90/347 in Genetics, reflecting its influence in the scientific community. Researchers are encouraged to explore the vast array of scholarly articles and engage with cutting-edge genomics research that is crucial for the evolution of various applications in medicine, agriculture, and environmental science. With its open access model, BMC Genomics ensures that groundbreaking research is freely available, fostering collaboration and accelerating scientific discovery on a global scale.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

Genes and Nutrition is a prominent open access journal published by BMC in the United Kingdom, dedicated to advancing knowledge at the intersection of nutrition, genetics, and human health. With the aim of making cutting-edge research available to a global audience, the journal has been a vital platform for sharing discoveries since its inception in 2007, and it continues to thrive with a convergence period extending to 2024. Recognized for its high-quality contributions, Genes and Nutrition is rated in the Q2 category within both Endocrinology, Diabetes, and Metabolism and Genetics as of 2023, reflecting its esteemed position in these fields (Scopus Ranks leaderboard places it at #72/244 and #109/347, respectively). This journal is an invaluable resource for researchers, professionals, and students alike, fostering collaboration and innovation in the understanding of how genetic factors influence nutrition and health outcomes. Accessible to all since 2016, it encourages dialogue and discovery, positioning itself as a leader in genetic and nutritional science.

Twin Research and Human Genetics, published by Cambridge University Press, is a leading academic journal that focuses on the vital intersections of genetics, human development, and twin studies. With an ISSN of 1832-4274 and E-ISSN 1839-2628, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in advancing their understanding of genetic influences on human health and behavior. In its dedication to disseminating high-quality research, Twin Research and Human Genetics holds impressive category quartile rankings, including Q2 in Pediatrics, Perinatology, and Child Health, and Q3 in both Genetics (Clinical) and Obstetrics and Gynecology as of 2023. The journal has a converged publication timeline from 2005 to 2024, providing a longstanding platform for rigorous scientific inquiry and discussion in its specialized fields. As an open-access title, it fosters accessibility to vital findings and promotes collaboration among scholars worldwide, ensuring that groundbreaking research reaches a broader audience. Positioned within a challenging and competitive landscape, this journal stands out for its commitment to excellence and its pivotal role in shaping the future of genetic research and its implications for health across the lifespan.

GENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.

HUMAN MOLECULAR GENETICS, published by Oxford University Press, is a premier journal in the field of genetics, with an established reputation since its inception in 1992. With an impressive Q1 ranking in various categories, including Genetics, Clinical Genetics, and Molecular Biology, this journal engages a diverse readership by reporting significant advances in our understanding of the genetic basis of human health and disease. The journal has achieved notable rankings within Scopus, particularly in Clinical Genetics, making it a key resource for professionals and researchers aiming to stay at the forefront of genetic research. Although it operates under a traditional access model, it remains committed to disseminating high-quality research that informs clinical practice and enhances knowledge in the genetic field. The journal's impact factor signifies its crucial role in shaping contemporary genetic research and its application in medicine. As the field continues to evolve, HUMAN MOLECULAR GENETICS serves not only as an academic repository but also as a vital platform for innovation and discussion among students, researchers, and clinicians.

GENETICS SELECTION EVOLUTION is a prominent open-access journal published by BMC since 1989, situated in the United Kingdom. With a focus on evolutionary genetics and the mechanisms of selection, this journal serves as a pivotal platform for researchers, professionals, and students in the fields of Animal Science, Ecology, and Genetics. Notably, it has achieved remarkable rankings, being categorized in Q1 for various disciplines, reflecting its high impact and contribution to scientific discourse. The journal boasts an impressive recognition in the Scopus rankings, sitting at the 94th percentile in Animal Science and Zoology, and 86th percentile in Ecology and Evolution, underscoring its influence in these domains. Offering open access since its inception, it ensures broad dissemination of knowledge, allowing critical research findings to reach a wider audience. As we converge into its upcoming issues, the journal continues to foster the exploration of innovative genetic research and selection processes, shaping the future of evolutionary studies.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.